MapLight TherapeuticsMPLT
那斯達克 · USD
13.77
+0.63
(+4.79%)
收盤 09/05 03:59 (UTC+8)
09/05 03:59 (UTC+8)
MapLight TherapeuticsMPLT
13.77
+0.63
(+4.79%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - |
營業費用 | 63,548 | 64,503 | 83,377 | 31,500 | 30,663 | 23,543 | 22,777 | 20,894 | 57,282 |
研發費用 | 53,435 | 53,684 | 64,623 | 27,093 | 26,846 | 19,787 | 20,713 | 16,814 | 49,675 |
推銷及管理費用 | 10,113 | 10,819 | 18,754 | 4,407 | - | - | 2,064 | 4,080 | 7,607 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - |
營業利益 | -63,548 | -64,503 | -83,377 | -31,500 | -30,663 | -23,543 | -22,777 | -20,894 | -57,282 |
其他收入及費用 | 3,356 | 3,835 | 3,829 | 2,081 | - | - | - | - | 587 |
利息費用 | - | - | - | - | - | - | - | - | - |
稅前純益 | -60,192 | -60,668 | -79,548 | -29,419 | -29,845 | -22,340 | -21,229 | -19,016 | -55,709 |
所得稅 | - | - | - | - | - | - | - | - | - |
稅後純益 | -60,192 | -60,668 | -79,548 | -29,419 | -29,845 | -22,340 | -21,229 | -19,016 | -55,709 |
基本每股稅後盈餘(元) | -1.32 | -1.34 | -2.47 | -0.71 | -0.72 | -0.54 | - | -0.73 | - |
稀釋每股稅後盈餘(元) | -1.32 | -1.34 | 87.14 | -37.24 | -0.72 | -0.54 | - | -0.73 | - |
基本平均股數(千股) | 45431.00 | 45208.00 | 32148.00 | 41428.00 | 41428.00 | - | - | 26175.00 | - |
稀釋平均股數(千股) | 45431.00 | 45208.00 | 32148.00 | 41428.00 | 41428.00 | - | - | 26175.00 | - |
還原基本每股稅後盈餘(元) | -1.32 | -1.34 | -2.47 | -0.71 | -0.72 | -0.54 | - | -0.73 | - |
還原稀釋每股稅後盈餘(元) | -1.32 | -1.34 | 87.14 | -37.24 | -0.72 | -0.54 | - | -0.73 | - |
還原基本平均股數(千股) | 45,431 | 45,208 | 32,148 | 41,428 | 41,428 | - | - | 26,175 | - |
還原稀釋平均股數(千股) | 45,431 | 45,208 | 32,148 | 41,428 | 41,428 | - | - | 26,175 | - |
EBITDA(千元) | -61,044 | -61,320 | -80,850 | -29,747 | -29,845 | -22,340 | -21,035 | -18,829 | -55,153 |